Genomic diversity Mycophenolic acid Multiplex PCR Gastrointestinal protozoa Molecular approach PCR panel Cryptococcosis Digestive parasites Coproscopy Cytochrome b Fungaemia PIG1 Penicillium Malaria Plasmodium P falciparum Molecular diagnosis qPCR LAMP Bio-Evolution Biosynex Airway microbiome Atovaquone Autoimmune Diseases Talaromyces Delphi method ELISA Anti-inflammatory Non-human primates Rheumatoid Dhfr Exposome Pneumocystis jirovecii cytochrome b CYB atovaquone selective pressure Traitement P jirovecii Infections CYB Monoterpene indole alkaloids Arthritis 3-beta-D-glucan Antiparasitaire Environment Ocular toxoplasmosis Non-tuberculous mycobacteria Glioblastoma Radioresistance Ceruloplasmin Iron Metabolism Hypoxia Candida Fungemia Serology Antirheumatic Agents Toxoplasmose oculaire Cell wall Uveitis Hot spots Pneumocystis jirovecii Pneumocystis jirovecii gsc1 1 3-beta-D-glucan echinocandins genomic diversity hot spots Epidemiological cut-off values Cystic fibrosis Echinocandins Catharanthus roseus Commiphora wildii Genotypes Diagnosis Treatment Heptane Cryptococcal meningitis Solid-organ transplantation Transplantation Smoking Aspergillosis Glucocorticoids Mucormycosis Mycobiome Diversité génétique C albicans Malignancy IMPDH Human immunodeficiency virus DHN-melanin Serodiagnosis RNA-seq Gradient concentration strip–specific Invasive fungal infections C glabrata Diversité génomique Delphi study Anti-inflammatoire Selection Aspergillus Essential oil Scedosporium apiospermum Transmission Co-product valorization Particulate matter HIV-seronegative Apocynaceae Antifungal susceptibility Méthotrexate CRISPR-Cas9 Epidemiology Dogs Methotrexate Dihydrofolate reductase Selective pressure Pneumocystis jirovecii dhfr dihydrofolate reductase genetic diversity methotrexate Pneumocytosis Anti-parasitic Genetic diversity Candidemia Gsc1